News - fasudil


Current filters:


Popular Filters

Actelion to appeal even though US court cuts original verdict by nearly $170 million in dispute with Asahi


Despite a final judgement issued on Friday by the Superior Court of the State of California, USA, to…

ActelionAsahi KaseiBiotechnologyfasudilFinancialLegalLicensing

Actelion granted motion for new trial in Asahi damages dispute


Europe’s largest biotech company, Actelion (SIX: ATLN), announced this morning that, the Superior…

ActelionAsahi KaseiBiotechnologyfasudilFinancialLegal

Actelion to appeal final jury verdict in Asahi Kasei litigation in US Court


Switzerland-based Actelion (SIX: ATLN) today commented on the verdict issued with regard to Japan’s…

ActelionAsahi KaseiBiotechnologyCardio-vascularCoTherixfasudilLegalLicensing

Back to top